Terms: = Pancreatic cancer AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha
414 results:
1. The MUC1-HIF-1α signaling axis regulates pancreatic cancer pathogenesis through polyamine metabolism remodeling.
Murthy D; Attri KS; Suresh V; Rajacharya GH; Valenzuela CA; Thakur R; Zhao J; Shukla SK; Chaika NV; LaBreck D; Rao CV; Hollingsworth MA; Mehla K; Singh PK
Proc Natl Acad Sci U S A; 2024 Apr; 121(14):e2315509121. PubMed ID: 38547055
[TBL] [Abstract] [Full Text] [Related]
2. NNT-AS1 in CAFs-derived exosomes promotes progression and glucose metabolism through miR-889-3p/HIF-1α in pancreatic adenocarcinoma.
Zhang P; Wang Q; Lu W; Zhang F; Wu D; Sun J
Sci Rep; 2024 Mar; 14(1):6979. PubMed ID: 38521881
[TBL] [Abstract] [Full Text] [Related]
3. microRNA-15a-5p suppresses hypoxia-induced tumor growth and chemoresistance in bladder cancer by binding to eIF5A2.
Yang J; Xiang H; Cheng M; Jiang X; Chen Y; Zheng L; Yan S; Zhang S; Zhang C; Chen W; Chen D
Neoplasma; 2024 Feb; 71(1):60-69. PubMed ID: 38506035
[TBL] [Abstract] [Full Text] [Related]
4. Metabolomic Investigations into Hypoxia-Mediated Metabolic Reprogramming of pancreatic cancer Cells.
Chumak V; Rajacharya GH; Singh PK
Methods Mol Biol; 2024; 2755():191-200. PubMed ID: 38319579
[TBL] [Abstract] [Full Text] [Related]
5. cancer-associated fibroblasts promote stemness maintenance and gemcitabine resistance via HIF-1α/miR-21 axis under hypoxic conditions in pancreatic cancer.
Deng K; Zou F; Xu J; Xu D; Luo Z
Mol Carcinog; 2024 Mar; 63(3):524-537. PubMed ID: 38197482
[TBL] [Abstract] [Full Text] [Related]
6. AMPK-HIF-1α signaling enhances glucose-derived de novo serine biosynthesis to promote glioblastoma growth.
Yun HJ; Li M; Guo D; Jeon SM; Park SH; Lim JS; Lee SB; Liu R; Du L; Kim SH; Shin TH; Eyun SI; Park YY; Lu Z; Lee JH
J Exp Clin Cancer Res; 2023 Dec; 42(1):340. PubMed ID: 38098117
[TBL] [Abstract] [Full Text] [Related]
7. In vitro and In vivo evidence demonstrating chronic absence of Ref-1 Cysteine 65 impacts Ref-1 folding configuration, redox signaling, proliferation and metastasis in pancreatic cancer.
Mijit M; Kpenu E; Chowdhury NN; Gampala S; Wireman R; Liu S; Babb O; Georgiadis MM; Wan J; Fishel ML; Kelley MR
Redox Biol; 2024 Feb; 69():102977. PubMed ID: 38056311
[TBL] [Abstract] [Full Text] [Related]
8. Hypoxia mediates immune escape of pancreatic cancer cells by affecting miR-1275/AXIN2 in natural killer cells.
Ou Z; Lu Y; Xu D; Luo Z
Front Immunol; 2023; 14():1271603. PubMed ID: 38035113
[TBL] [Abstract] [Full Text] [Related]
9. LIPH contributes to glycolytic phenotype in pancreatic ductal adenocarcinoma by activating LPA/LPAR axis and maintaining ALDOA stability.
Han L; Jiang Y; Shi M; Gan L; Wu Z; Xue M; Zhu Y; Xiong C; Wang T; Lin X; Shen B; Jiang L; Chen H
J Transl Med; 2023 Nov; 21(1):838. PubMed ID: 37990271
[TBL] [Abstract] [Full Text] [Related]
10. AEP-cleaved DDX3X induces alternative RNA splicing events to mediate cancer cell adaptation in harsh microenvironments.
Zhang W; Cao L; Yang J; Zhang S; Zhao J; Shi Z; Liao K; Wang H; Chen B; Qian Z; Xu H; Wu L; Liu H; Wang H; Ma C; Qiu Y; Ge J; Chen J; Lin Y
J Clin Invest; 2023 Nov; 134(3):. PubMed ID: 37988165
[TBL] [Abstract] [Full Text] [Related]
11. Long non-coding RNAs and tyrosine kinase-mediated drug resistance in pancreatic cancer.
Li D; Weng S; Zeng K; Xu H; Wang W; Shi J; Chen J; Chen C
Gene; 2024 Feb; 895():148007. PubMed ID: 37981080
[TBL] [Abstract] [Full Text] [Related]
12. Evaluations of the combined use of blood- and tissue-based protein biomarkers for pancreatic cancer.
Wiewiora M; Jopek J; Świętochowska E; Grynkiewicz M; Piecuch J
Clin Hemorheol Microcirc; 2024; 86(3):383-393. PubMed ID: 37955083
[TBL] [Abstract] [Full Text] [Related]
13. A SIRT6 Inhibitor, Marine-Derived Pyrrole-Pyridinimidazole Derivative 8a, Suppresses Angiogenesis.
Song N; Tang Y; Wang Y; Guan X; Yu W; Jiang T; Lu L; Gu Y
Mar Drugs; 2023 Sep; 21(10):. PubMed ID: 37888452
[TBL] [Abstract] [Full Text] [Related]
14. Nuclear GRP78 Promotes Metabolic Reprogramming and Therapeutic Resistance in pancreatic Ductal Adenocarcinoma.
Zhao T; Jiang T; Li X; Chang S; Sun Q; Kong F; Kong X; Wei F; He J; Hao J; Xie K
Clin Cancer Res; 2023 Dec; 29(24):5183-5195. PubMed ID: 37819952
[TBL] [Abstract] [Full Text] [Related]
15. PNU-74654 Induces Cell Cycle Arrest and Inhibits EMT Progression in pancreatic cancer.
Chien TL; Wu YC; Lee HL; Sung WW; Yu CY; Chang YC; Lin CC; Wang CC; Tsai MC
Medicina (Kaunas); 2023 Aug; 59(9):. PubMed ID: 37763649
[No Abstract] [Full Text] [Related]
16. Blood-based protein biomarkers and red blood cell aggregation in pancreatic cancer.
Wiewiora M; Jopek J; Świętochowska E; Sławomir G; Piecuch J; Gąska M; Piecuch J
Clin Hemorheol Microcirc; 2023; 85(4):371-383. PubMed ID: 37718785
[TBL] [Abstract] [Full Text] [Related]
17. Stem cell factor modulates HIF-1α levels and diminishes 5-FU sensitivity in 5-FU resistant pancreatic cells by altering the anabolic glucose metabolism.
Xiang F; Luo F
J Biochem Mol Toxicol; 2023 Dec; 37(12):e23487. PubMed ID: 37718545
[TBL] [Abstract] [Full Text] [Related]
18. Reduced expression of phosphorylated ataxia-telangiectasia mutated gene is related to poor prognosis and gemcitabine chemoresistance in pancreatic cancer.
Xun J; Ohtsuka H; Hirose K; Douchi D; Nakayama S; Ishida M; Miura T; Ariake K; Mizuma M; Nakagawa K; Morikawa T; Furukawa T; Unno M
BMC Cancer; 2023 Sep; 23(1):835. PubMed ID: 37674118
[TBL] [Abstract] [Full Text] [Related]
19. Vav1-dependent Rac1 activation mediates hypoxia-induced gemcitabine resistance in pancreatic ductal adenocarcinoma cells through upregulation of HIF-1α expression.
Zhu C; Hu H; Ma Y; Xiong S; Zhu D
Cell Biol Int; 2023 Nov; 47(11):1835-1842. PubMed ID: 37545183
[TBL] [Abstract] [Full Text] [Related]
20. Selective HIF2A Inhibitors in the Management of Clear Cell Renal cancer and Von Hippel-Lindau-Disease-Associated Tumors.
Suárez C; Vieito M; Valdivia A; González M; Carles J
Med Sci (Basel); 2023 Jun; 11(3):. PubMed ID: 37489462
[TBL] [Abstract] [Full Text] [Related]
[Next]
